MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized not only by classical pathological hallmarks—including amyloid plaques, hyperphosphorylated tau tangles, and neuronal loss—but also by early cerebrovascular dysfunction, which is increasingly recognized as a critical contributor to disease pathogenesis and cognitive decline [67,68,69].